Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
弥漫性大B细胞淋巴瘤五年生存者发生后续恶性肿瘤的治疗特异性风险
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.102248
Geurts, Y M; Neppelenbroek, S I M; Aleman, B M P; Janus, C P M; Krol, A D G; van Spronsen, D J; Plattel, W J; Roesink, J M; Verschueren, K M S; Zijlstra, J M; Koene, H R; Nijziel, M R; Schimmel, E C; de Jongh, E; Ong, F; Te Boome, L C J; van Rijn, R S; Böhmer, L H; Ta, B D P; Visser, H P J; Posthuma, E F M; Bilgin, Y M; Muller, K; van Kampen, D; So-Osman, C; Vermaat, J S P; de Weijer, R J; Kersten, M J; van Leeuwen, F E; Schaapveld, M
